Perspective of patients with autoimmune diseases on COVID-19 vaccination

Laura Boekel¹, Femke Hooijberg¹, Zoé L E van Kempen², Erik H Vogelzang³, Sander W Tas⁴, Joep Killestein², Michael T Nurmohamed^{1

4}, Maarten Boers^{1

3}, Taco W Kuijpers⁵, S Marieke van Ham^{6

7}, Filip Eftimov⁸, Luuk Wieske⁸, Theo Rispens⁷, Gertjan J Wolbink^{1

7}

Affiliations

¹ Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Amsterdam 1056 AB, Netherlands.
² Department of Neurology, Vrije Universiteit, Amsterdam UMC, Amsterdam, Netherlands.
³ Department of Epidemiology and Data Science, Vrije Universiteit, Amsterdam UMC, Amsterdam, Netherlands.
⁴ Amsterdam Rheumatology and Immunology Center, Department of Rheumatology and Clinical Immunology, University of Amsterdam, Amsterdam, Netherlands.
⁵ Department of Pediatric Immunology, Vrije Universiteit, Amsterdam UMC, Amsterdam, Netherlands.
⁶ Swammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam, Netherlands.
⁷ Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Center, Amsterdam, Netherlands.
⁸ Department of Neurology and Neurophysiology, Amsterdam Neuroscience, University of Amsterdam, Amsterdam, Netherlands.

Laura Boekel et al. Lancet Rheumatol. 2021 Apr.

. 2021 Apr;3(4):e241-e243.

doi: 10.1016/S2665-9913(21)00037-0. Epub 2021 Feb 22.

¹ Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Amsterdam 1056 AB, Netherlands.
² Department of Neurology, Vrije Universiteit, Amsterdam UMC, Amsterdam, Netherlands.
³ Department of Epidemiology and Data Science, Vrije Universiteit, Amsterdam UMC, Amsterdam, Netherlands.
⁴ Amsterdam Rheumatology and Immunology Center, Department of Rheumatology and Clinical Immunology, University of Amsterdam, Amsterdam, Netherlands.
⁵ Department of Pediatric Immunology, Vrije Universiteit, Amsterdam UMC, Amsterdam, Netherlands.
⁶ Swammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam, Netherlands.
⁷ Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Center, Amsterdam, Netherlands.
⁸ Department of Neurology and Neurophysiology, Amsterdam Neuroscience, University of Amsterdam, Amsterdam, Netherlands.

No abstract available

References

1. Anderson RM, Vegvari C, Truscott J, Collyer BS. Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination. Lancet. 2020;396:1614–1616. - PMC - PubMed
1. Guidry JPD, Laestadius LI, Vraga EK, Miller CA, Perrin PB, Burton CW, et al. Willingness to get the COVID-19 vaccine with and without emergency use authorization. Am J Infect Control. 2021;49:137–142. - PMC - PubMed
1. Doornekamp L, van Leeuwen L, van Gorp E, Voeten H, Goeijenbier M. Determinants of vaccination uptake in risk populations: a comprehensive literature review. Vaccines. 2020;8:480. - PMC - PubMed
1. Westra J, Rondaan C, van Assen S, Bijl M. Vaccination of patients with autoimmune inflammatory rheumatic diseases. Nat Rev Rheumatol. 2015;11:135–145. - PubMed
1. Akiyama S, Hamdeh S, Micic D, Sakuraba A. Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis. Ann Rheum Dis. 2021;80:384–391. - PubMed